TY - JOUR
T1 - Percutaneous Sclerotherapy for Venous Malformations Using Polidocanol under Fluoroscopy
AU - Mimura, Hidefumi
AU - Kanazawa, Susumu
AU - Yasui, Kotaro
AU - Fujiwara, Hiroyasu
AU - Hyodo, Tsuyoshi
AU - Mukai, Takashi
AU - Dendo, Shuichi
AU - Iguchi, Toshihiro
AU - Hiraki, Takao
AU - Koshima, Isao
AU - Hiraki, Yoshio
PY - 2003/10
Y1 - 2003/10
N2 - This retrospective study evaluated the safety and efficacy of using polidocanol with X-ray fluoroscopy for percutaneous sclerotherapy of venous malformations of the limbs, head, and neck. The subjects were 16 of 18 patients who presented to our department with venous malformations. Two patients were excluded because they were unlikely to benefit from the treatment. Of the 16 included in the study, 1 could not be treated because of inaccessibility, and another was lost to follow-up. Among the 14 cases that we were able to follow-up, 11 cases had had pain as their primary symptom. Following treatment, this symptom remained unchanged in 1 patient, was improved in 4, and had disappeared in 6; however, there was a recurrence of pain for 3 of these patients. Two patients had sought treatment for cosmetic purposes; following treatment, the lesion disappeared in one and showed a significant reduction in the other. The remaining patient presented with a primary symptom of mouth bleeding, which disappeared following treatment. There were no critical complications. Percutaneous sclerotherapy of venous malformations using polidocanol is safe and effective, and permits repeat treatments. The efficacy is especially good for resolving pain, and complications are minor. It is desirable to use fluoroscopy for these procedures.
AB - This retrospective study evaluated the safety and efficacy of using polidocanol with X-ray fluoroscopy for percutaneous sclerotherapy of venous malformations of the limbs, head, and neck. The subjects were 16 of 18 patients who presented to our department with venous malformations. Two patients were excluded because they were unlikely to benefit from the treatment. Of the 16 included in the study, 1 could not be treated because of inaccessibility, and another was lost to follow-up. Among the 14 cases that we were able to follow-up, 11 cases had had pain as their primary symptom. Following treatment, this symptom remained unchanged in 1 patient, was improved in 4, and had disappeared in 6; however, there was a recurrence of pain for 3 of these patients. Two patients had sought treatment for cosmetic purposes; following treatment, the lesion disappeared in one and showed a significant reduction in the other. The remaining patient presented with a primary symptom of mouth bleeding, which disappeared following treatment. There were no critical complications. Percutaneous sclerotherapy of venous malformations using polidocanol is safe and effective, and permits repeat treatments. The efficacy is especially good for resolving pain, and complications are minor. It is desirable to use fluoroscopy for these procedures.
KW - Fluoroscopy guidance
KW - Polidocanol
KW - Sclerotherapy
KW - Venous malformation
UR - http://www.scopus.com/inward/record.url?scp=10744223278&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=10744223278&partnerID=8YFLogxK
M3 - Article
C2 - 14679400
AN - SCOPUS:10744223278
SN - 0386-300X
VL - 57
SP - 227
EP - 234
JO - Acta medica Okayama
JF - Acta medica Okayama
IS - 5
ER -